The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; Teva
Research Funding - Celgene/Bristol-Myers Squibb
Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM).
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda
Research Funding - Bluebird Bio (Inst)
 
Caitlin Costello
Honoraria - Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Takeda
Consulting or Advisory Role - Celgene; Takeda
Research Funding - Celgene (Inst); Janssen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Bhagirathbhai R. Dholaria
Research Funding - Angiocrine Bioscience; Janssen; Pfizer; Poseida Therapeutics; Takeda
 
Melhem M. Solh
Speakers' Bureau - Abbvie; Amgen; Bristol-Myers Squibb; Seagen
Research Funding - Partner therapeutics
 
Moshe Y. Levy
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Sanofi; Seagen; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Sanofi; Seagen; Takeda
Research Funding - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Sanofi; Seagen; Takeda
 
Michael H Tomasson
No Relationships to Disclose
 
Harman Dube
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Feng Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Kai Hsin Liao
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Cynthia Basu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Athanasia Skoura
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Edward Michael Chan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Suzanne Trudel
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - Amgen; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Pfizer
 
Andrzej J. Jakubowiak
Leadership - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millennium; Sanofi; Skyline Diagnostics; Takeda
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millennium; Sanofi; Skyline Diagnostics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millennium; Sanofi; Skyline Diagnostics; Takeda
 
Michael P Chu
No Relationships to Disclose
 
Cristina Gasparetto
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen
 
Andrew Dalovisio
No Relationships to Disclose
 
Michael Sebag
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Ortho; Karyopharm Therapeutics; Novartis; Takeda
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Patent but with no associated royalties or profit
 
Alexander M. Lesokhin
Honoraria - Amgen; Bristol-Myers Squibb; Genmab; Janssen
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc